VITALOGRAPH are to create 41 new jobs in Ennis.
On Monday, Vitalograph confirmed it was creating 60 new jobs across Ennis and Limerick City, bringing its global headcount to 500, 350 of which are based in Ireland.
A spokesperson for the company has confirmed to The Clare Echo that of the 60 new positions, 41 will be located in Ennis with the remaining 19 in Limerick.
Established in Buckinghamshire in 1963, Vitalograph this year marks its sixtieth anniversary. Since 1974, its primary location for manufacturing, research and development has been in its Ennis base in the Gort Rd Industrial Estate. Cecil Street office was opened in 2022, following the announcement of a €10m investment.
Ambrose Downey, Chief People Officer at Vitalograph said: “Ireland’s leadership in the MedTech sector is well documented; we punch well above our weight. Vitalograph is no exception. This recruitment drive is a strategic move to meet the increasing global demand for our respiratory diagnostic solutions and clinical trial services. Vitalograph is having a meaningful impact tackling some of the world’s biggest healthcare challenges, and by building skilled teams, Vitalograph will be able reach its fullest potential”.
The company designs and manufactures medical devices that help clinicians detect, diagnose, and manage respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. The new roles include positions in clinical trial support, engineering, IT and finance.
Notably, Vitalograph is seeking 50 Data Processors (Cough Analysts) to increase its capabilities for clinical trial support. The roles will be a boost for local employment, and a great number of these positions are entry-level, suiting a wide variety of people with diverse skills and backgrounds.
Since the early 2000s, Vitalograph has been enabling pharmaceutical companies researching therapies for respiratory conditions through its clinical trial services.
More recently, in partnership with internationally renowned cough researchers, Vitalograph developed the world’s first commercially available system that objectively measures cough frequency in investigational drug trials. Data Processors are responsible for analysing the digitised cough sounds and they play a vital role in enabling pharmaceutical companies to develop new therapies for chronic cough.
Last October, CEO of Vitalograph Ireland, Frank Keane said their plans for the development of a new Centre of Excellence in Ennis “will offer many opportunities”. They acquired the Ballymaley Enterprise and Innovation Centre building from Clare County Council and Ennis 2040 DAC for the development of its new Clinical Trials Services Centre of Excellence.
